Abstract
Fosun Pharmaceutical and Shanghai drugs open innovation model. QIAGEN gains SFDA approval to market careHPV Test. AstraZeneca's heart drug wins approval. SIMM explores a novel cationic core-shell lipo-nanoparticles for ocular gene drug delivery. TaiGen and TTY Biopharm jointly develop and commercialize a novel topoisomerase I inhibitor for cancer treatment. iHuman Institute inauguration held. Sihuan Pharmaceutical collaborates with NeuroVive to develop two innovative cardio-cerebral vascular products. PerkinElmer acquires China-based infectious disease diagnostics company.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
